STOCK TITAN

CVS Health (NYSE: CVS) grants options and RSUs to EVP Capozzi

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CVS HEALTH Corp executive Heidi B. Capozzi reported routine equity compensation and related tax withholding. She received stock options for 64,670 shares of common stock at $71.82 per share, exercisable in three equal annual installments starting March 31, 2027 and expiring on March 31, 2036. She was also granted 10,025 restricted stock units at $71.82 per share under the 2017 Incentive Compensation Plan, with restrictions lapsing in three equal installments beginning March 31, 2027. In a separate transaction, 1,334 common shares at $72.49 were surrendered to cover withholding taxes on RSU vesting, leaving her with 13,023 directly held common shares.

Positive

  • None.

Negative

  • None.
Insider CAPOZZI HEIDI B
Role EVP and Chief People Officer
Type Security Shares Price Value
Tax Withholding Common Stock 1,334 $72.49 $97K
Grant/Award Stock Option 64,670 $71.82 $4.64M
Grant/Award Common Stock (Restricted) 10,025 $71.82 $720K
Holdings After Transaction: Common Stock — 13,023 shares (Direct); Stock Option — 64,670 shares (Direct); Common Stock (Restricted) — 84,450 shares (Direct)
Footnotes (1)
  1. Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. Option becomes exercisable in three equal annual installments, commencing 3/31/2027.
Tax-withholding shares 1,334 shares at $72.49 Common stock surrendered to cover RSU tax on 2026-04-01
Common shares held 13,023 shares Direct CVS common stock ownership after tax withholding
Stock option grant 64,670 options at $71.82 Options on CVS common stock granted 2026-03-31
Option vesting schedule 3 annual installments from 2027-03-31 Exercisable in thirds; expiration 2036-03-31
RSU grant 10,025 RSUs at $71.82 Restricted stock units granted 2026-03-31
Restricted shares following 84,450 shares Total restricted common stock following RSU grant
restricted stock units financial
"Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
withholding taxes financial
"Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units."
Withholding taxes are amounts a payer or government takes out of payments — such as wages, interest, or dividends — before the recipient gets the money, functioning like a cashier keeping part of a bill to pay taxes on your behalf. For investors this matters because it reduces the cash they actually receive, affects net returns and yield calculations, and may require additional paperwork or treaty claims to recover or offset the withheld amount against final tax bills.
Incentive Compensation Plan financial
"awarded pursuant to Issuer's 2017 Incentive Compensation Plan."
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
restricted stock units awarded financial
"Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan."
Option becomes exercisable financial
"Option becomes exercisable in three equal annual installments, commencing 3/31/2027."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CAPOZZI HEIDI B

(Last)(First)(Middle)
ONE CVS DRIVE

(Street)
WOONSOCKET RHODE ISLAND 02895

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP and Chief People Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock (Restricted)03/31/2026A(1)10,025A$71.8284,450D
Common Stock04/01/2026F(2)1,334D$72.4913,023D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option(3)$71.8203/31/2026A64,67003/31/202703/31/2036Common Stock64,670$71.8264,670D
Explanation of Responses:
1. Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.
2. Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.
3. Option becomes exercisable in three equal annual installments, commencing 3/31/2027.
/s/ Heidi B. Capozzi04/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did CVS (CVS) grant to Heidi B. Capozzi?

CVS granted Heidi B. Capozzi stock options for 64,670 shares at $71.82 and 10,025 restricted stock units. These awards are part of routine executive compensation and are tied to future service-based vesting schedules starting in 2027.

When do Heidi B. Capozzi’s new CVS stock options vest and expire?

The stock options vest in three equal annual installments starting March 31, 2027 and expire on March 31, 2036. This means the executive gains exercisability gradually, with a long-term horizon before final expiration of the options.

How do the new restricted stock units for CVS (CVS) vest?

The 10,025 restricted stock units vest in three equal installments starting March 31, 2027. These units were granted under CVS’s 2017 Incentive Compensation Plan and align the executive’s compensation with long-term company performance and retention.

Why did Heidi B. Capozzi surrender 1,334 CVS shares?

She surrendered 1,334 common shares at $72.49 to pay withholding taxes due on the vesting and settlement of restricted stock units. This tax-withholding disposition is not an open-market sale but a standard mechanism to satisfy tax obligations.

How many CVS common shares does Heidi B. Capozzi hold after these transactions?

Following the tax-withholding disposition, she directly holds 13,023 CVS common shares. This figure reflects her remaining direct ownership after surrendering shares to cover tax obligations on vesting restricted stock units reported in the same filing.

What plan governs Heidi B. Capozzi’s new CVS restricted stock units?

The restricted stock units were awarded under CVS’s 2017 Incentive Compensation Plan. This plan provides equity-based compensation, such as RSUs and options, to align executives’ interests with shareholders and support long-term retention and performance objectives.